• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肺癌组织中p53和K-ras突变的分布

Distribution of p53 and K-ras mutations in human lung cancer tissues.

作者信息

Gao H G, Chen J K, Stewart J, Song B, Rayappa C, Whong W Z, Ong T

机构信息

Division of Respiratory Disease Studies, National Institute for Occupational Safety and Health, Morgantown, WV 26505-2845, USA.

出版信息

Carcinogenesis. 1997 Mar;18(3):473-8. doi: 10.1093/carcin/18.3.473.

DOI:10.1093/carcin/18.3.473
PMID:9067544
Abstract

Studies were performed to examine the mutational pattern of K-ras exons 1 and 2 and p53 exons 5-8 in lung cancer tissues from 27 Chinese patients (10 smokers, 17 non-smokers) using single-stranded conformational polymorphism and DNA sequencing. K-ras mutations were found in 13/27 tumors (48%); all mutations were clustered in exon 1 and distributed between codons 9 and 32. The frequency and number of patients with K-ras mutations between smokers and non-smokers were not different, except that a high frequency of G --> A transitions (11/11) was found in non-smokers. Among cell types, K-ras mutations were found in 7/13 (54%) squamous cell carcinoma (SC) and 5/12 (42%) adenocarcinoma (AC) patients. A --> T transversions (all six transversions) were present only in SC. In p53, 18/27 (67%) tumors contained mutations in exons 7 and 8, frequently at codons 226, 270, 275 and 281. The number of tumors with p53 mutations in smokers (70%) and in non-smokers (65%) was similar, and the mutation frequency did not differ except for a higher number of G --> A (6/7) and T --> C (5/6) transitions in non-smokers. Among cell types, the number of tumors with p53 mutations was 9/13 (69%) in SC and 8/12 (67%) in AC. The A --> G (11/16) transitions and A --> C (4/4) transversions in p53 were more frequent in SC than in AC (P < 0.04 for A --> G; P < 0.02 for A --> C). The varying mutation patterns in both the K-ras and p53 genes between smokers and non-smokers and among cell types suggest that other than cigarette smoke, environmental and dietary factors may also be involved in the genesis of lung cancer among these patients.

摘要

开展了多项研究,运用单链构象多态性和DNA测序技术,检测27例中国肺癌患者(10例吸烟者,17例非吸烟者)肺癌组织中K-ras基因第1和第2外显子以及p53基因第5至8外显子的突变模式。在27例肿瘤中有13例(48%)发现K-ras突变;所有突变均聚集在第1外显子,分布于密码子9至32之间。吸烟者与非吸烟者之间K-ras突变患者的频率和数量并无差异,只是在非吸烟者中发现较高频率的G→A转换(11/11)。在细胞类型中,13例鳞状细胞癌(SC)患者中有7例(54%)以及12例腺癌(AC)患者中有5例(42%)发现K-ras突变。A→T颠换(所有6次颠换)仅出现在SC中。在p53基因方面,27例肿瘤中有18例(67%)在第7和第8外显子存在突变,常见于密码子226、270、275和281。吸烟者(70%)和非吸烟者(65%)中发生p53突变的肿瘤数量相似,除了非吸烟者中G→A(6/7)和T→C(5/6)转换数量较多外,突变频率并无差异。在细胞类型中,SC中有9例(69%)肿瘤发生p53突变,AC中有8例(67%)。p53基因中的A→G(11/16)转换和A→C(4/4)颠换在SC中比在AC中更常见(A→G,P<0.04;A→C,P<0.02)。吸烟者与非吸烟者之间以及不同细胞类型中K-ras和p53基因的突变模式各异,这表明除香烟烟雾外,环境和饮食因素可能也参与了这些患者肺癌的发生。

相似文献

1
Distribution of p53 and K-ras mutations in human lung cancer tissues.人肺癌组织中p53和K-ras突变的分布
Carcinogenesis. 1997 Mar;18(3):473-8. doi: 10.1093/carcin/18.3.473.
2
Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.吸烟与不吸烟女性肺癌中p53和K-ras基因突变的比较。
Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 1):297-302.
3
Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung: unique spectra involving G to A transitions and G to T transversions in both histologic types.肺腺癌与肺鳞状细胞癌中p53突变的比较:两种组织学类型中均存在涉及G到A转换和G到T颠换的独特谱型。
Lung Cancer. 2003 May;40(2):141-50. doi: 10.1016/s0169-5002(03)00035-7.
4
A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.一种使用福尔马林固定石蜡包埋组织对非小细胞肺癌中K-ras和p53基因进行突变分析的通用方法。
Diagn Mol Pathol. 1995 Dec;4(4):266-73. doi: 10.1097/00019606-199512000-00007.
5
Molecular analysis of p53 and K-ras in lung carcinomas of coal miners.煤矿工人肺癌中p53和K-ras的分子分析。
Int J Mol Med. 2001 Oct;8(4):453-9. doi: 10.3892/ijmm.8.4.453.
6
Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer.p53和K-ras基因的突变作为非小细胞肺癌的预后因素
Int J Oncol. 1998 Mar;12(3):553-63. doi: 10.3892/ijo.12.3.553.
7
p53 and K-ras mutations in lung cancers from former and never-smoking women.既往吸烟和从不吸烟女性肺癌中的p53和K-ras基因突变
Cancer Res. 2001 Jun 1;61(11):4350-6.
8
Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.p53热点密码子对苯并(a)芘二醇环氧化物(BPDE)的易变性以及非肿瘤性人肺中p53突变的频率。
Cancer Res. 2001 Sep 1;61(17):6350-5.
9
High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.黄曲霉毒素B1诱导的小鼠肺肿瘤中p53突变的高频及异质性分布
Cancer Res. 1999 Aug 1;59(15):3634-40.
10
K-ras gene mutations in non-small cell lung cancer in Japanese.日本非小细胞肺癌中的K-ras基因突变
Oncol Rep. 2001 Jul-Aug;8(4):889-92. doi: 10.3892/or.8.4.889.

引用本文的文献

1
SMURF2 Facilitates GAP17 Isoform 1 Membrane Displacement to Promote Mutant p53-KRAS Oncogenic Synergy.SMURF2促进GAP17亚型1的膜移位以增强突变型p53-KRAS致癌协同作用。
Mol Cancer Res. 2025 Jun 3;23(6):530-541. doi: 10.1158/1541-7786.MCR-24-0701.
2
Deletion of cyclooxygenase-2 inhibits K-ras-induced lung carcinogenesis.环氧化酶-2的缺失抑制K-ras诱导的肺癌发生。
Oncotarget. 2015 Nov 17;6(36):38816-26. doi: 10.18632/oncotarget.5558.
3
Kras, Egfr, and Tp53 Mutations in B6C3F1/N Mouse and F344/NTac Rat Alveolar/Bronchiolar Carcinomas Resulting from Chronic Inhalation Exposure to Cobalt Metal.
慢性吸入钴金属导致的B6C3F1/N小鼠和F344/NTac大鼠肺泡/细支气管癌中的Kras、Egfr和Tp53突变
Toxicol Pathol. 2015 Aug;43(6):872-82. doi: 10.1177/0192623315581192. Epub 2015 Jun 9.
4
Oxidation of p53 through DNA charge transport involves a network of disulfides within the DNA-binding domain.通过DNA电荷传输对p53进行氧化涉及DNA结合域内的二硫键网络。
Biochemistry. 2015 Jan 27;54(3):932-41. doi: 10.1021/bi501424v. Epub 2015 Jan 13.
5
IKK is a therapeutic target in KRAS-Induced lung cancer with disrupted p53 activity.IKK是KRAS诱导的、p53活性受干扰的肺癌中的一个治疗靶点。
Genes Cancer. 2014 Apr;5(1-2):41-55. doi: 10.18632/genesandcancer.5.
6
Beta-adrenergic signaling in the development and progression of pulmonary and pancreatic adenocarcinoma.β-肾上腺素能信号传导在肺腺癌和胰腺腺癌发生发展中的作用
Curr Cancer Ther Rev. 2012 May 1;8(2):116-127. doi: 10.2174/157339412800675351.
7
Tobacco smoke: chemical carcinogenesis and genetic lesions.烟草烟雾:化学致癌作用与基因损伤
Ochsner J. 1999 Jul;1(3):130-5.
8
[Gender-associated differences of lung cancer and mechanism].[肺癌的性别相关差异及机制]
Zhongguo Fei Ai Za Zhi. 2011 Jul;14(7):625-30. doi: 10.3779/j.issn.1009-3419.2011.07.12.
9
Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis.MKRN1 E3 连接酶对 p53 和 p21 的差异调节控制细胞周期停滞和凋亡。
EMBO J. 2009 Jul 22;28(14):2100-13. doi: 10.1038/emboj.2009.164. Epub 2009 Jun 18.
10
Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns.人类癌症的遗传通路和突变谱:特定部位和暴露特异性模式。
Carcinogenesis. 2007 Sep;28(9):1851-8. doi: 10.1093/carcin/bgm176. Epub 2007 Aug 11.